| Company/Division name | Piramal Pharma Solutions |
| Parent company | Piramal Pharma Solutions |
| Type of work | Manufacturing |
| Reshoring category: | Foreign Direct Investment |
| Year reshoring announced: | 2025 |
| Year reshoring implemented or to be implemented: | 2027 |
| Capital investment ($): | 90 |
| City reshored to: | Lexington |
| State(s) reshored to: | KY |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | Pharmaceuticals |
| What domestic positive factors made reshoring more attractive? | Govt. Policy and subsidies, Proximity to customers/market |
